The replace, reduce, and refine framework guides how researchers choose and improve experimental systems. Replacement seeks evidence without whole animals, reduction limits animal use when some use remains necessary, and refinement aims to lessen burdens while preserving scientific value. In bioengineering, this framework encourages development of increasingly human-relevant models rather than treating animal studies as the only benchmark.
Different engineered models capture different levels of biological organization. Cell cultures can reveal responses at the cellular level, while three-dimensional tissues and organoids represent more complex tissue features. Organ-on-chip systems add controlled interactions within engineered environments, and computational models provide another way to evaluate responses. Model selection therefore depends on the biological question and the response being measured.
Controlled conditions let investigators evaluate a defined response while limiting the variability associated with a whole organism. This can improve experimental control and make it easier to examine cellular toxicity, drug activity, disease processes, or tissue interactions separately. Such focused measurements help bioengineers identify how a system responds and compare evidence across designed experimental conditions.
A major scientific consideration is how well evidence translates to human health. Animal findings may not fully capture human biology, whereas human-oriented cultures, tissues, organoids, chips, and computational models are designed to recreate aspects of it. These alternatives therefore address both an ethical concern and the research problem of obtaining evidence more directly relevant to human responses.
A typical bioengineering workflow begins by defining the response of interest, such as toxicity, drug activity, disease behavior, or tissue interaction. Researchers then select a suitable engineered or computational model, apply the relevant test condition, and measure the resulting response. The final assessment considers whether the model produces scientifically useful, human-relevant evidence under controlled conditions.
Measurements can address several distinct outcomes rather than producing a single general result. Investigators may assess cellular toxicity, determine whether a drug shows activity, examine disease processes, or study interactions between tissues. Matching the measurement to the model’s biological level is important: cell cultures support cellular readouts, while tissue-oriented systems support questions about tissue behavior.
These approaches are especially relevant to therapeutic research because they can examine drug activity, toxicity, disease processes, and tissue interactions in engineered systems. Their use may accelerate research while improving experimental control and addressing ethical concerns. In bioengineering, this application connects cell cultures, tissues, organoids, chips, and computational models with the need for more human-relevant biomedical evidence.